Strategic Foundation: Why Commercial Ready Manufacturing Should Be Considered from Day One
Phacilitate
| 10 Feb 2026
In a complex, volatile global market, manufacturability is no longer something to address “when the time comes”-it must be built into the therapy from day one
Join the industry in Barcelona | 7 - 9 September 2026 for 3 days of deal-making, data-driven insight and serious momentum across cell and gene therapy. From early science to commercial scale, this is where the full ecosystem connects, collaborates and moves the field forward.
